Fenpipalone

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C17H22N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6TVC31DEDE, chemically known as 5-(2-(3,6-dihydro-4-phenyl-1(2h)-pyridyl)ethyl)-3-methyl-2-oxazolidinone but generally known as fenpipalone, which bears US NIH Compound Identifier 30822. European Medicines Agency schedules Fenpipalone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07587MIG. The term FENPIPALONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). FENPIPALONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fenpipalone under HS 29349990 and SITC 51579. As of Q4 2014, FENPIPALONE remains the US FDA Preferred Term for this commodity. Fenpipalone bears US NLM identifiers UMLS ID C2825251 and NCI Concept Code C80550. SMILES: O1C(CCN2CCC(=CC2)C2CCCCC2)CN(C1=O)C.